Phase II Study of Neoadjuvant 5-Fu + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-4-32
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Nature

Related search

A Single-Arm, Nonrandomized Phase II Trial of Neoadjuvant Gemcitabine and Oxaliplatin in Patients With Resectable Pancreas Adenocarcinoma

Annals of Surgery
Surgery
2014English

A Phase II Trial of Haptaplatin/5-Fu and Leucovorin for Advanced Stomach Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2005English

Total Tumour Volume as a Prognostic Factor in Patients With Resectable Colorectal Cancer Liver Metastases

BJS open
Surgery
2020English

A Pilot Phase II Study of Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Resectable Colon Cancer

Chinese Journal of Cancer Research
Cancer ResearchOncology
2016English

Docetaxel Versus Paclitaxel Combined With 5-Fu and Leucovorin in Advanced Gastric Cancer: Combined Analysis of Two Phase II Trials

Cancer Research and Treatment
Cancer ResearchOncology
2009English

Phase II Study of Gefitinib, Fluorouracil, Leucovorin, and Oxaliplatin Therapy in Previously Treated Patients With Metastatic Colorectal Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2005English

Pathological Response Grade of Colorectal Liver Metastases Treated With Neoadjuvant Chemotherapy

HPB
HepatologyGastroenterology
2010English

An Evaluation of Neoadjuvant Chemoradiotherapy for Patients With Resectable Pancreatic Ductal Adenocarcinoma

HPB Surgery
SurgeryHepatology
2013English

Impact of Neoadjuvant Chemotherapy on Clinical Risk Scores and Survival in Patients With Colorectal Liver Metastases

Annals of Surgical Oncology
OncologySurgery
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy